Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Over the past two decades, significant progress in understanding of the pathogenesis of type
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
P Kolkhir, CA Akdis, M Akdis, C Bachert… - Nature reviews. Drug … - pubmed.ncbi.nlm.nih.gov
Over the past two decades, significant progress in understanding of the pathogenesis of type
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
P Kolkhir, CA Akdis, M Akdis, C Bachert… - Nature Reviews. Drug …, 2023 - zora.uzh.ch
Over the past two decades, significant progress in understanding of the pathogenesis of type
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.
P Kolkhir, CA Akdis, M Akdis, C Bachert… - Nature reviews. Drug …, 2023 - europepmc.org
Over the past two decades, significant progress in understanding of the pathogenesis of type
2 chronic inflammatory diseases has enabled the identification of compounds for more than …
2 chronic inflammatory diseases has enabled the identification of compounds for more than …